Molecular Formula:
C46H64N14O12S2
Relative Molecular Mass:
1069.23 g/mol
CAS-Number:
16679-58-6 (net), 62288-83-9 (acetate), 62357-86-2 (acetate trihydrate)
Long-term Storage:
-20 ± 5°C
Synonyms:
DDAVP; (Deamino-Cys1,D-Arg8)-Vasopressin
Sequence:
3-Mercaptopropionyl-Tyr-Phe-Gln-Asn-Cys-Pro-D-Arg-Gly-NH2 acetate salt (Disulfide bond)
Fields of Application:
Nocturnal enuresis
Central diabetes insipidus, polyuria, polydipsia
Mild and moderate forms of hemophilia A and von Willebrand disease
Active Substance:
Desmopressin (DDAVP) is a synthetic analog of vasopressin with low vasopressor activity. Apart from its increasing effect
on water resorption by the kidneys, desmopressin raises plasma levels of von Willebrand factor and factor VIII.
In veterinary medicine, desmopressin is applied in the treatment of canine and feline diabetes insipidus.
Company Profile
Company: Shenzhen JYMed Technology Co., Ltd
Found in 2009, our peptide plant is located in Nanjing, Jiangsu province and it has set up a facility of 30,000 square meters in compliance with cGMP guideline. The manufacture facility has been audited and inspected by both domestic and international clients.
公司简介
深圳市健元医药科技有限公司是一家专业从事多肽系列产品研究开发和生产销售的高新技术企业。主要产品包括多肽原料药、美容多肽、兽用多肽、客户定制肽等。
健元医药始终秉持“求实创新”的企业精神,在产品的研发上精益求精,组建了一支规模超过50人的专业化研发团队;现拥有涉及多肽系列产品的发明专利26项,其中7项专利已授权,PCT专利1项,进入实审状态的发明专利18项。
健元医药研发中心位于深圳市高新技术产业园内,配备有国际先进的多肽产品研发仪器设备,生产基地位于南京市溧水经济开发区星银医药园内。工厂严格按照GMP要求进行生产和质量管理,可以为客户生产和供应符合cGMP要求的多肽系列产品。
健元医药以其优质的多肽产品,强大
成立日期 |
2009-04-14
(16年)
|
注册资本 |
8950万人民币
|
员工人数 |
100-500人 |
年营业额 |
¥ 100万以内 |
主营行业 |
中间体,医药原料 |
经营模式 |
工厂 |